期刊文献+

血清胃蛋白酶原联合Hp-IgG抗体检测对胃癌筛查的价值分析 被引量:7

The value of serum pepsinogen combined with Hp-IgG antibody detection for gastric cancer screening
下载PDF
导出
摘要 目的研究血清胃蛋白酶原与Hp-IgG抗体的表达情况,了解联合检测两者在胃癌筛查中的意义。方法选取2012年1月~2013年1月期间到我院体检的东莞本地人为研究对象,采用酶联免疫口发附试验(ELISA)行血清胃蛋闩酶原(PGI)、胃蛋白酶原Ⅱ(PGⅡ)及Hp-IgG抗体水平检测,对自愿接受内镜及病理组织活检者行上消化道内镜及病理活检检查。结果共收集到4010名研究对象,Hp+组PG+占23.77%,Hp-组PG+占3.17%,两组比较差异有统计学意义(P〈0.05)。有1080例行胃镜及病理活组织检查,其中慢性浅表性胃炎675例,慢性萎缩性胃炎219例,肠E皮化生150例,不典型增生16例,胃癌20例,慢性浅表性胃炎组Hp-lgG抗体的阳性率低于慢性萎缩性胃炎组、肠上皮化生组、不典型增生组和胃癌组(P〈0.05)。单独以PGI≤71.5μG/L或PGI/PGⅡ(PGR)比值≤4.5为胃癌筛查阳性标准时发现胃癌16例,筛查胃癌的灵敏度为80.00%,特异性39.91%,胃癌漏诊率20.00%;若PG联合Hp抗体为筛查标准,筛查出胃癌12例,而灵敏度下降至60.00%,漏诊率上升至40.00%。结论Hp感染率存不问胃部病变中不一致,血清lOG检测对胃癌的筛查具有重要意义,Hp-IgG抗体联合PG检测增加胃癌筛查的漏诊率。 Objective To explore the expression level of serum pepsinogen and HP - IgG antibody, and investigate the value of them for gastric cancer screening. Methods Dong guan locale people were collected from January 2012 to January 2013, who came for physical examination. PGI, PGII and Hp -IgG antibody were detected by ELISA, and PG I/PG II (PGR) was calculated. Gastrointestinal endoscopy and biopsy pathology were carried on who were agreed. Results A total of 4010 people were collected. The positive rate of Hp infection in PG positive group was 23.7%, and 3.17% in PG negative group, differences were statistically significant (P〈0.05). 1080 people underwent gastroscopy and biopsy pathology examination, including 675 cases of chronic superficial gastritis, 219 cases of chronic atrophic gastritis, 150 cases of intestinal meta- plasia, 16 case of atypical hyperplasia and 20 cases of gastric cancer. The positive rate of Hp-lgG in chronic superficial gastritis group was lower than chronic atrophic gastritis group, intestinal metaplasia group, atypical hyperplasia group and gastric cancer group, differences were statistically significant too (P〈0.05). When PG I less than 71.5 μg/L or PGR less than 4.5 alone was used to he gastric cancer screening stand- ard, the sensitivity was 80.00%, specificity was 39.91% , positive predictive value was 2.45%, the rate of missed diagnosis was 20.00%. If PG standard combined Hp antibody to be the screening standard, the sensitivity M1 to 60.00%, and the rate of missed diagnosis rose up to 40.00%. Conclusion Hp infection rate was different in different gastric lesions. Serum PG detection has a great significance for gastric screening,Hp-IgG antibody combined PG detection increase the rate of omission diagnosis for gastric cancer screening.
出处 《湘南学院学报(医学版)》 2015年第4期14-17,共4页 Journal of Xiangnan University(Medical Sciences)
基金 东莞市科技局项目(201110515046234)
关键词 血清胃蛋白酶原 幽门螺杆菌 胃癌 酶联免疫吸附试验 serum PG, gastric cancer, screening, ELISA
  • 相关文献

参考文献12

  • 1Yoon H, Kim N. Diagnosis and manngement of high risk group for gastric cancer[ J ]. Gut and Liver, 2015, ! ( 9 ) : 5 - 17.
  • 2Zoalfaghari A,Aletaha N, ltoushan N, et at. Accuracy of pep- sinogens tot early diagnosis of atrophic gastritis and gastric cancer in Iranian population [ J ]. Med J Islam Repub Iran, 2014,28 : 150-157.
  • 3Miki K, Fujishiro M, Kodashima S, et al. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese popu- lation[ J]. Dig Endosc,2009,21 (2) :78-81.
  • 4Mukoubayashi C,Yanaoka K, Ohata H, et al. Serum pepsino- gen and gastric cancer screening [ J ]. Intern Med, 2007, 46 (6) :261-266.
  • 5于中麟,冀明,杨迅,张澍田,黄晓俊,张志镒,吴正奇,徐红,熊元治,马颖才.血清胃蛋白酶原对胃癌普查的价值探讨[J].中华消化内镜杂志,2008,25(10):512-515. 被引量:33
  • 6International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter polori [ M ]. in IARC mono- graphs on the evaluation of carcinogenic risks to humans. Ly- on : IARC MONOGRAHP, 1994:218.
  • 7胡伏莲.幽门螺杆菌感染的流行病学[J].中国医刊,2007,42(2):17-18. 被引量:146
  • 8曹勤,冉志华,萧树东.血清胃蛋白酶原、胃泌素-17和幽门螺杆菌IgG抗体筛查萎缩性胃炎和胃癌[J].胃肠病学,2006,11(7):388-394. 被引量:113
  • 9Shikata K, Ninomiya T, Yonemoto K, et al. Optimal cutoff val- ue of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study [J]. Scand] Gastroen- tero1,2012,47 (66) :669-765.
  • 10Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with helicobacter pylor- pylori infection increases risk of gastric of gasrtic cancer [ J ]. Int J Cancer, 2004,109 : 138-143.

二级参考文献53

  • 1李哲夫,王德昭,乐竹琴.胃泌素与胃癌[J].国外医学(消化系疾病分册),1993,13(2):69-72. 被引量:11
  • 2三木一正.ベブシンノゲン-法.东京:医学书院,1998.
  • 3三木一正.胃かん罹患ハイリスク群の检诊と诊疗[J].成人病と生活习惯病,2007,37:1232-1234.
  • 4柳冈公彦 冈政志 大烟博 他.前癌状态としての慢性胃炎の评价と胃癌检诊[J].消化器内视镜,2006,28:463-468.
  • 5三木一正.ベブシンノゲン-法による胃かん检诊[J].临床消化器内科,2008,23:358-363.
  • 6三木一正.胃かんハイリスクストラテジ-にもとづく胃内视镜检诊[J].Gastrointest Endosc,2007,49:2451-2460.
  • 7Ferlay J,Bray F,Pisani P,Parkin DM.GLOBOCAN 2000:Cancer Incidence,Mortality and Prevalence Worldwide.Version 1.0.IARC Cancer Base No.5.Lyon:IARC Press,2001.
  • 8Sipponen P,Kekki M,Haapakoski J,Ihamaki T,Siurala M.Gastric cancer risk in chronic atrophic gastritis:statistical calculations of cross-sectional data.Int J Cancer,1985,35:173~177.
  • 9Koga M,Miyakawa K,Ikeda S.Annual Report of Gastroenterological Mass Survey in Japan,2002.Tokyo:Japanese Society of Gastroenterology Mass Survey.2004.
  • 10Sipponen P,Ranta P,Helske T,Kaariainen I,Maki T,Linnala A,Suovaniemi O,Alanko A,Harkonen M.Serum levels of amidated gastrin-17 and pepsinogen Ⅰ in atrophic gastritis:an observational case-control study.Scand J Gastroenterol,2002,37:785~791.

共引文献297

同被引文献55

引证文献7

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部